Open AccessThe antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation
Author(s) -
Katie J Smith,
Danielle Minns,
Brian J. McHugh,
R. Holloway,
Richard A. O’Connor,
Anna Williams,
Lauren Melrose,
Rhoanne C. McPherson,
Véronique E. Miron,
Donald J. Davidson,
Emily Gwyer Findlay
Publication year - 2022
Publication title -
plos biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.127
H-Index - 271
eISSN - 1545-7885
pISSN - 1544-9173
DOI - 10.1371/journal.pbio.3001554
Subject(s) - cathelicidin , experimental autoimmune encephalomyelitis , biology , immunology , autoimmunity , multiple sclerosis , microglia , interleukin 17 , inflammation , cytokine , interleukin 23 , immune system , innate immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom